Loading...

ANI Pharmaceuticals, Inc.

ANIP•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$78.64
$0.58(0.74%)
U.S. Market opens in 7h 12m

ANI Pharmaceuticals, Inc. (ANIP) Stock Overview

Explore ANI Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.8B
P/E Ratio20.49
EPS (TTM)$3.32
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$85.45
3 Months$91.45
1 Year Target$93.37

ANIP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ANI Pharmaceuticals, Inc. (ANIP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.94, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $93.37.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.49 and a market capitalization of 1.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.74%
5-Day Change
-0.59%
1-Month Change
7.27%
3-Month Change
-5.24%
6-Month Change
-16.55%
Year-to-Date (YTD) Change
-0.38%
1-Year Change
12.92%
3-Year Change
103.15%
5-Year Change
139.68%
All-Time (Max) Change
-63.21%

Contact Information

https://www.anipharmaceuticals.com
218 634 3500
210 Main Street West, Baudette, MN, 56623

Company Facts

897 Employees
IPO DateMay 5, 2000
CountryUS
Actively Trading

Frequently Asked Questions